Curative Inc. Acquires KorvaLabs, Inc.
May 19, 2020
Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.
- Buyers
- Curative Inc.
- Targets
- KorvaLabs, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Clinical Reference Laboratory Acquires Confirm BioSciences
December 9, 2020
Healthcare Services
Clinical Reference Laboratory (CRL), a large privately held clinical testing laboratory, has acquired Confirm BioSciences, a San Diego–based provider of screening tools and consumer-facing testing products. The acquisition will have Confirm operate as a subsidiary and is intended to expand CRL's lab testing and R&D capabilities while leveraging Confirm's large retail/customer base and COVID-19 testing pipeline.
-
Curia Acquires LakePharma to Expand Biologics R&D and Manufacturing Capabilities
February 14, 2022
Biotechnology
Curia (formerly AMRI) has acquired LakePharma Inc., a US-based biologics contract research, development and manufacturing organization with operations in California, Massachusetts and Texas. The deal adds LakePharma's six facilities and ~235 employees to Curia's global network, creating expanded end-to-end capabilities from discovery through GMP manufacturing for biologics.
-
CURE Pharmaceutical to Acquire Sera Labs for $20 Million
July 30, 2020
Consumer Products
CURE Pharmaceutical entered a memorandum of understanding to acquire 100% of privately held Sera Labs for $20 million in a deal composed primarily of CURE stock, with potential earn-outs of up to an additional $20 million. The acquisition adds Sera Labs' CBD-focused branded portfolio, DTC subscription model and retail/wholesale distribution (over 8,850 U.S. doors) to CURE's cGMP manufacturing and drug-delivery capabilities, with Sera Labs founder Nancy Duitch remaining in a leadership role.
-
Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence
June 17, 2021
Healthcare Services
Solvias has acquired Canton, Massachusetts-based Chemic Laboratories, Inc., giving the Swiss analytical testing and contract research company a U.S. foothold and complementary laboratory testing capabilities. Chemic's co-founders will join Solvias' leadership and continue to run U.S. operations; financial terms were not disclosed.
-
MedVenture Health Acquires Canyon Labs
May 19, 2023
Healthcare Services
MedVenture Health, a Salt Lake City-based private investment firm focused on medical devices and life sciences, has acquired Canyon Labs, an FDA-approved regulatory and laboratory testing services provider. The acquisition adds regulatory testing, analytical and microbiological capabilities (in a 17,000-sf facility) to MedVenture's portfolio to support its companies and accelerate product development and compliance.
-
Curvo Labs Acquires Strategic Healthcare Services, LLC
October 13, 2021
Healthcare Services
Curvo Labs, a healthcare supply chain technology company, has acquired Strategic Healthcare Services, LLC (SHS), a consulting firm focused on strategic sourcing and clinical spend management for providers and manufacturers. The acquisition will integrate SHS's advisory and analytical services into Curvo's AI-powered sourcing platform to broaden its capabilities; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.